Abstract: Blockchain-based workflow management for patient samples. In an embodiment, for each of a plurality of first devices, a request for a unique sample identifier is received from the first device, and, in response to the request, the unique sample identifier is generated and sent to the first device. Then, for each of a plurality of second devices and for each of a plurality of interactions, interaction information is received from the second device, a transaction is generated from the interaction information, and the transaction is recorded in an immutable ledger. The interaction information may comprise a unique sample identifier, a user identifier, a location, an event type, and a timestamp.

Abstract: Blockchain-based consumables management with support for offline instruments. In an embodiment, a user device scans a first machine-readable code on a consumable, scans a second machine-readable code displayed on a display of an instrument that is not communicatively connected to a blockchain network, decodes a consumable code from the first machine-readable code, decodes an instrument code from the second machine-readable code, broadcasts a transaction message, comprising the consumable code and the instrument code, to the blockchain network, receives a use code from the blockchain network, encodes the use code into a third machine-readable code, and displays the third machine-readable code, on a display of the user device, for scanning by the instrument.

Abstract: The present invention relates to a fluid transport system for an automated slide treatment apparatus for treating one or more tissue samples disposed on slides, whereby the slide treatment apparatus includes a plurality of slide treatment modules arranged to receive ones of the slides, and the fluid transport system includes a fluid dispensing robot configured by a controller to dispense a plurality of reagents to said ones of the slides received in the slide treatment modules to treat said one or more tissue samples respectively.

Abstract: Systems and methods for hybrid virtual and chemical staining of tissue samples are disclosed. In one aspect, an image analysis apparatus includes a memory coupled to an imaging device, and a hardware processor coupled to the memory. The hardware processor is configured to receive image data from the imaging device, the image data representative of a tissue sample in a first state, and perform virtual staining of the tissue sample based on the image data to generate one or more virtual stained images of the tissue sample. The hardware processor is further configured to order chemical staining of the tissue sample in the first state, receive one or more chemically stained images, and generate a set of the one or more virtual stained images of the tissue sample from the virtual staining and the one or more chemically stained images of the tissue sample from the chemical staining.

Abstract: The present invention relates to a fluid transport system for an automated slide treatment apparatus for treating one or more tissue samples disposed on slides, whereby the slide treatment apparatus includes a plurality of slide treatment modules arranged to receive ones of the slides, and the fluid transport system includes a fluid dispensing robot configured by a controller to dispense a plurality of reagents to said ones of the slides received in the slide treatment modules to treat said one or more tissue samples respectively.

Abstract: Blockchain-based workflow management for patient samples. In an embodiment, for each of a plurality of first devices, a request for a unique sample identifier is received from the first device, and, in response to the request, the unique sample identifier is generated and sent to the first device. Then, for each of a plurality of second devices and for each of a plurality of interactions, interaction information is received from the second device, a transaction is generated from the interaction information, and the transaction is recorded in an immutable ledger. The interaction information may comprise a unique sample identifier, a user identifier, a location, an event type, and a timestamp.

Abstract: The present invention relates to a fluid transport system for an automated slide treatment apparatus for treating one or more tissue samples disposed on slides, whereby the slide treatment apparatus includes a plurality of slide treatment modules arranged to receive ones of the slides, and the fluid transport system includes a fluid dispensing robot configured by a controller to dispense a plurality of reagents to said ones of the slides received in the slide treatment modules to treat said one or more tissue samples respectively.

Abstract: Blockchain-based consumables management with support for offline instruments. In an embodiment, a user device scans a first machine-readable code on a consumable, scans a second machine-readable code displayed on a display of an instrument that is not communicatively connected to a blockchain network, decodes a consumable code from the first machine-readable code, decodes an instrument code from the second machine-readable code, broadcasts a transaction message, comprising the consumable code and the instrument code, to the blockchain network, receives a use code from the blockchain network, encodes the use code into a third machine-readable code, and displays the third machine-readable code, on a display of the user device, for scanning by the instrument.

Abstract: The present invention relates to a fluid transport system for an automated slide treatment apparatus for treating one or more tissue samples disposed on slides, whereby the slide treatment apparatus includes a plurality of slide treatment modules arranged to receive ones of the slides, and the fluid transport system includes a fluid dispensing robot configured by a controller to dispense a plurality of reagents to said ones of the slides received in the slide treatment modules to treat said one or more tissue samples respectively.

Abstract: Novel Amadori reaction compounds have the formula R.sub.1 --NH--R.sub.2, wherein R.sub.1 comprises the D-form of a 1-amino-1-deoxy-2-ketose radical derived from a sugar radical selected from the group of glucose, xylose, galactose, rhamnose, fructose, mannose, 6-deoxyglucose, glucosamine and galactosamine, and R.sub.2 comprises the L-form of an aminoacid or peptide radical selected from the group of serine, glycine, proline, histidine, arginine, alanine, aspartic acid, glutamic acid, phenylalanine, treonine, cysteine, cystine, glutamine, asparagine, methionine, tyrosine, hydroxyproline, tryptophane, valine isoleucine, lysine and leucine. Compounds and combinations of compounds having the general formula R.sub.1 '--NH--R.sub.2 ', wherein R.sub.1 ' comprises a 1-amino-1-deoxy-2-ketose radical derived from the group of simple sugars, oligo- and polysaccharides, and R.sub.